Allspring Global Investments Holdings, LLC Janux Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 5,865 shares of JANX stock, worth $246,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,865
Previous 5,851
0.24%
Holding current value
$246,740
Previous $265,000
18.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding JANX
# of Institutions
171Shares Held
37.8MCall Options Held
85.3KPut Options Held
654K-
Ra Capital Management, L.P. Boston, MA9.17MShares$386 Million5.81% of portfolio
-
Janus Henderson Group PLC London, X02.52MShares$106 Million0.06% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.4MShares$101 Million3.93% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$98.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.08MShares$87.3 Million0.17% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.75B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...